| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/23/2003 | CN1430976A Medicine for treating liver disease |
| 07/23/2003 | CN1430975A Extractive of ocean star worm, its preparing method and application |
| 07/23/2003 | CN1430972A Powder prepared from snake tissues for dipping in feet |
| 07/23/2003 | CN1430962A Skin liniment |
| 07/23/2003 | CN1430961A Compound of ceferamet used for injection |
| 07/23/2003 | CN1115414C Virus carrier used for gene therapy |
| 07/23/2003 | CN1115345C Carbohydrate derivatives |
| 07/23/2003 | CN1115153C Medicine synergist |
| 07/23/2003 | CN1115147C Improved method for preparing potassium clavulanate |
| 07/23/2003 | CN1115145C Improving tolerability of pharmaceutically active beta-amino acids |
| 07/22/2003 | US6596923 Methods and compositions to identify swine genetically resistant to F18 E. coli associated diseases |
| 07/22/2003 | US6596907 Halogenating alkoxyphenol; reacting with p-dihalobenzene in presence of copper or salt; etherification; ether fission |
| 07/22/2003 | US6596791 Polymer complexes of glucuronoglucanes |
| 07/22/2003 | US6596772 Relates to trifluoromethyl sulfonyl and trifluoromethyl sulfonamido compounds and the physiologically acceptable salts and the prodrugs thereof. These compounds are expected to modulate the activity of protein tyrosine enzymes which are |
| 07/22/2003 | US6596763 Method for counteracting infections caused by bacteria, fungi or virus such as Herpes Simplex Virus in skin or mucosal membranes, in particular genital membranes, of a mammal. The method comprises topically administering to skin or mucous |
| 07/22/2003 | US6596754 Preventives/remedies for multiple organ failure |
| 07/22/2003 | US6596729 Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors |
| 07/22/2003 | US6596720 Potentiating an anti-HIV activity of trifluridine and derivatives in thereof in a mammal, including human, comprising administering to said mammal, including human, an effective amount of a thymidine phosphorylase inhibitor and |
| 07/22/2003 | US6596700 Methods of treating hepatitis delta virus infection with β-L-2'-deoxy-nucleosides |
| 07/22/2003 | US6596691 Administering therapeutically effective amount of bactericidal/permeability-increasing protein product to a human suffering from meningococcemia |
| 07/22/2003 | US6596533 Polypeptide for use in the treatment of infections and cell proliferative disorders |
| 07/22/2003 | US6596530 Lactobacillus for use in the generation of food product |
| 07/22/2003 | US6596313 Nutritional supplement and methods of using it |
| 07/22/2003 | US6596298 Pullulan and antimicrobially effective amounts of thymol, methyl salicylate, eucalyptol and menthol |
| 07/22/2003 | US6596297 Biodegradable microbicidal vaginal barrier device |
| 07/22/2003 | US6596283 Chemically-modified group B polysaccharides of Neisseria meningitidis for use as vaccines |
| 07/22/2003 | US6596282 Treatment of chronic viral infections with M. vaccae |
| 07/22/2003 | US6596279 Immunodeficiency recombinant poxvirus |
| 07/22/2003 | CA2109320C Peptide nucleic acids |
| 07/22/2003 | CA2045891C Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleotide linkages |
| 07/21/2003 | CA2416791A1 A receptor-ligand pairing for immune response |
| 07/21/2003 | CA2368656A1 Receptor-ligand pairing for anti-inflammatory response |
| 07/17/2003 | WO2003058248A2 Diagnostics and vaccines for mycrobacterium paratuberculosis infections |
| 07/17/2003 | WO2003058233A1 Method of screening compound having fungal cell wall synthesis inhibitory activity |
| 07/17/2003 | WO2003058021A2 Novel apoptosis-inducing dna sequences |
| 07/17/2003 | WO2003057885A1 Hiv-1 virus tat-protein mutants |
| 07/17/2003 | WO2003057856A2 Dominant negative proteins and methods thereof |
| 07/17/2003 | WO2003057830A2 Compositions and methods for hydroxylating epothilones |
| 07/17/2003 | WO2003057829A2 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 07/17/2003 | WO2003057823A2 Epitope synchronization in antigen presenting cells |
| 07/17/2003 | WO2003057730A1 Ligand for g-protein coupled receptor gpr43 and uses thereof |
| 07/17/2003 | WO2003057725A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 07/17/2003 | WO2003057724A1 Dab9 DERIVATIVES OF LIPOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING AND USING THE SAME |
| 07/17/2003 | WO2003057699A1 Dibenzodiazepine derivates, their preparation and use |
| 07/17/2003 | WO2003057696A1 Deazapurines and uses thereof |
| 07/17/2003 | WO2003057677A1 Anti-retroviral 5,6-disubstituted acyclopyrimidine nucleoside derivatives |
| 07/17/2003 | WO2003057676A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 07/17/2003 | WO2003057671A1 Biaryl compound and use thereof |
| 07/17/2003 | WO2003057668A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use |
| 07/17/2003 | WO2003057666A2 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057252A1 Human mast cell-expressed membrane proteins |
| 07/17/2003 | WO2003057229A1 Antiviral and antipyretic formulation and the preparation method thereof |
| 07/17/2003 | WO2003057227A1 Use of polysaccharide derivatives as anti-infective substances |
| 07/17/2003 | WO2003057224A1 Apoptosis inductor |
| 07/17/2003 | WO2003057219A1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 07/17/2003 | WO2003057212A1 Polyamide derivatives possessing antibacterial, antifungal or antitumor activity |
| 07/17/2003 | WO2003057211A1 Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases. |
| 07/17/2003 | WO2003057196A1 Drug mixture with enhanced dissolution rate |
| 07/17/2003 | WO2003057178A2 Viral capsid assembly intermediates |
| 07/17/2003 | WO2003057166A2 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 07/17/2003 | WO2003057148A2 Use of biomolecular targets in the treatment and visualization of tumors |
| 07/17/2003 | WO2003057147A2 Useful aroyl pyrrole heteroaryl methanones and methanols |
| 07/17/2003 | WO2003057144A2 Change inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057135A2 Aqueous compositions containing metronidazole |
| 07/17/2003 | WO2003048114A3 Bacterial enzyme inhibitors |
| 07/17/2003 | WO2003043979A3 Pharmaceutically active compounds and methods of use thereof |
| 07/17/2003 | WO2003038057A3 Genetic vaccine against human immunodeficiency virus |
| 07/17/2003 | WO2003032962A3 Dual action antibiotics |
| 07/17/2003 | WO2003030827A3 Compositions for and methods of treating and preventing sirs/sepsis |
| 07/17/2003 | WO2003022252A3 Combinatorial type (several vehicles within a housing) controlled release drug delivery device |
| 07/17/2003 | WO2003011329A3 Vaccine for prophylaxis and therapy of dermatophytosis in veterinary and human medicine |
| 07/17/2003 | WO2003008573A3 Silencing of gene expression by sirna |
| 07/17/2003 | WO2003008410A3 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 07/17/2003 | WO2003000896A3 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 07/17/2003 | WO2002081646A3 Epitope sequences |
| 07/17/2003 | WO2002074335A3 Equine herpesvirus vaccine |
| 07/17/2003 | WO2002059286A3 Adenylate cyclases |
| 07/17/2003 | WO2002055693A3 Method for inhibiting the expression of a target gene |
| 07/17/2003 | WO2002046190A3 Sulfonamido ether substituted imidazoquinolines |
| 07/17/2003 | WO2002031134A3 Novel serine protease genes related to dppiv |
| 07/17/2003 | WO2002022805A3 Modulation of il-2- and il-15-mediated t cell responses |
| 07/17/2003 | WO2002009677A3 Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs |
| 07/17/2003 | WO2001094369A3 Heterocycle derivatives and methods of use for treating anthrax infection |
| 07/17/2003 | US20030135028 Human serine protease and serpin polypeptides |
| 07/17/2003 | US20030135026 Compounds and methods for diagnosis of tuberculosis |
| 07/17/2003 | US20030134889 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 07/17/2003 | US20030134888 Substituted diaminopyrazoles; treating diseases, such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. coatings for implantable medical devices, such as prostheses, artificial valves, etc. |
| 07/17/2003 | US20030134858 Treatment of inflammation associated disorders, such as arthritis, colon cancer, and Alzheimer's disease |
| 07/17/2003 | US20030134856 Method and structure for inhibiting activity of serine elastases |
| 07/17/2003 | US20030134850 Hydrazinyl and nitrogen oxide pyrazoles |
| 07/17/2003 | US20030134849 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors |
| 07/17/2003 | US20030134840 Novel compounds |
| 07/17/2003 | US20030134839 5-(Alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles |
| 07/17/2003 | US20030134836 Substituted arylamine derivatives and methods of use |
| 07/17/2003 | US20030134829 X is a ring having at least 4 atoms in the ring; K is hydrocarbyl group; Rh1 is an optional halo group; Rh2 is an optional halo group; at least one of Rh1 and Rh2 is present; Rs is any one of a sulphamate group, a phosphonate, |
| 07/17/2003 | US20030134810 Delivery of pharmacologically active agents associated with polymeric biocompatible materials. Compositions comprising a first, negatively charged pharmacologically active agent such as an oligonucleotide and a polycationic polymer such as |
| 07/17/2003 | US20030134805 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
| 07/17/2003 | US20030134787 Engineered to noncovalently bind to heat shock proteins; (ii) to compositions comprising such conjugate peptides, optionally bound to heat shock protein; and (iii) to methods of using such compositions to induce an immune response in a subject in |
| 07/17/2003 | US20030134779 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections |
| 07/17/2003 | US20030134430 Novel amino acid sequences for human caenorhabditis elegans-like protein polypeptides |